Effectiveness and Efficiency of Platelet Rich Plasma in the Treatment of Diabetic Ulcers

Title:Effectiveness and Efficiency of Platelet Rich Plasma in the Treatment of Diabetic Ulcers

Volume: 16 Issue: 7

Author(s): Raquel Cobos, Felipe Aizpuru, Naiara Parraza, Eduardo Anitua and Gorka Orive

Affiliation:

Keywords: Cost-benefit analysis, skin ulcers, platelet-rich plasma, varicose ulcers.

Abstract: “There is a growing body of evidence suggesting that wound healing in chronic diabetic foot ulcers is growth factor dependent, and that the therapeutic delivery of these growth factors to wounds topically, has the potential ability to accelerate wound healing in conjunction with conventional wound care”. There is, however, confusion about the utility of platelet rich plasma because the studies that have evaluated them use a wide range of products (different platelet and leukocyte concentrations, different techniques and frequencies of application, very heterogeneous simple, and different endpoints) making almost impossible to compare data and draw conclusions. In this study, we have analyzed the different platelet rich plasma products from a new perspective: cost-efficiency. According to our data, we observe that platelet rich plasma is a cost-effective option that allows faster healing of ulcers, and that should be taken into account in patients with long evolution ulcers.

Cite this article as:

Cobos Raquel, Aizpuru Felipe, Parraza Naiara, Anitua Eduardo and Orive Gorka, Effectiveness and Efficiency of Platelet Rich Plasma in the Treatment of Diabetic Ulcers, Current Pharmaceutical Biotechnology 2015; 16 (7) . https://dx.doi.org/10.2174/138920101607150427111926